Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (28)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Astrocytic IGF-IRs induce adenosine-mediated inhibitory downregulation and improve sensory discrimination

    Journal of Neuroscience, Vol. 41, Núm. 22, pp. 4768-4781

  2. GSK-3 and Tau: A Key Duet in Alzheimer's Disease

    Cells, Vol. 10, Núm. 4

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis

    Autophagy, Vol. 16, Núm. 7, pp. 1279-1295

  2. Editorial: Shaping the Brain by Neuronal Cytoskeleton: From Development to Disease and Degeneration

    Frontiers in Cellular Neuroscience

2019

  1. Distinct functions for mammalian CLASP1 and -2 during neurite and axon elongation

    Frontiers in Cellular Neuroscience, Vol. 13

  2. Ovarian Hormone-Dependent Effects of Dietary Lipids on APP/PS1 Mouse Brain

    Frontiers in Aging Neuroscience, Vol. 11

  3. Role of tau N-terminal motif in the secretion of human tau by End Binding proteins

    PLoS ONE, Vol. 14, Núm. 1

2018

  1. Ovarian function modulates the effects of long-chain polyunsaturated fatty acids on the mouse cerebral cortex

    Frontiers in Cellular Neuroscience, Vol. 12

2017

  1. Atypical, non-standard functions of the microtubule associated Tau protein

    Acta neuropathologica communications, Vol. 5, Núm. 1, pp. 91

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. Intracellular and extracellular microtubule associated protein tau as a therapeutic target in Alzheimer disease and other tauopathies

    Expert Opinion on Therapeutic Targets, Vol. 20, Núm. 6, pp. 653-661

  4. Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system

    Neurobiology of Disease, Vol. 88, pp. 44-54

  5. Tau Structures

    Frontiers in Aging Neuroscience, Vol. 8, Núm. NOV

2015

  1. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake

    Neurobiology of Disease, Vol. 74, pp. 325-335

  2. Tau regulates the localization and function of End-binding proteins 1 and 3 in developing neuronal cells

    Journal of Neurochemistry, Vol. 133, Núm. 5, pp. 653-667

2014

  1. Crosstalk between axonal classical microtubule-associated proteins and end binding proteins during axon extension: Possible implications in neurodegeneration

    Journal of Alzheimer's Disease, Vol. 40, Núm. S1